Chongqing, China

Juanjuan Shan

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Chongqing Precision Biotech Co., Ltd.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Juanjuan Shan. Retrieved from https://idiyas.com/inventor/juanjuan-shan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Juanjuan Shan in CAR-T Cell Technology

Introduction

Juanjuan Shan is an innovative inventor based in Chongqing, China. He has made significant contributions to the field of biotechnology, particularly in the development of CAR-T cell technology. His work focuses on improving the efficacy and longevity of CAR-T cells, which are crucial in cancer treatment.

Latest Patents

Juanjuan Shan holds a patent titled "Hinge area and use of same in constructing car skeleton." This invention presents an improved hinge area that enhances the construction of CAR skeletons. The amino acid sequences of the improved hinge area are detailed in SEQ ID NO.1, SEQ ID NO.2, and SEQ ID NO.3. This innovation is designed to prolong the survival of CAR-T cells in vivo and improve their ability to infiltrate tumors.

Career Highlights

Juanjuan Shan is associated with Chongqing Precision Biotech Co., Ltd., where he applies his expertise in biotechnology. His work has been instrumental in advancing CAR-T cell therapies, which hold promise for treating various cancers.

Collaborations

Some of his notable coworkers include Wenxu Zhao and QianZhen Zhang, who contribute to the collaborative efforts in their research and development projects.

Conclusion

Juanjuan Shan's innovative work in CAR-T cell technology exemplifies the potential of biotechnology to transform cancer treatment. His contributions are paving the way for more effective therapies in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…